{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:06:28Z","timestamp":1790305588164,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41401-019-0239-3","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:04:23Z","timestamp":1557817463000},"page":"1259-1268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Interplay between Alzheimer\u2019s disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP\/PS1 transgenic mice"],"prefix":"10.1038","volume":"40","author":[{"given":"Xia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"239_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.3","volume":"47","author":"B Kim","year":"2015","unstructured":"Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med. 2015;47:e149.","journal-title":"Exp Mol Med"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S. Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages. Front Aging Neurosci. 2017;9:345.","journal-title":"Front Aging Neurosci"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/ATVBAHA.114.304591","volume":"35","author":"G Waither","year":"2015","unstructured":"Waither G, Obert P, Dutheil F, Chapier R, Lesourd B, Naughton G, et al. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction cross-sectional study. Arter Throm Vas. 2015;35:1022\u2013U318.","journal-title":"Arter Throm Vas"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","volume":"5","author":"E Blazquez","year":"2014","unstructured":"Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer\u2019s disease. Front Endocrinol. 2014;5:161.","journal-title":"Front Endocrinol"},{"key":"239_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JAD-2011-101392","volume":"25","author":"RO Kuljis","year":"2011","unstructured":"Kuljis RO, Salkovic-Petrisic M. Dementia, diabetes, Alzheimer\u2019s disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics. J Alzheimers Dis. 2011;25:29\u201341.","journal-title":"J Alzheimers Dis"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/1980-57642016dn11-020002","volume":"11","author":"AM de Nazareth","year":"2017","unstructured":"de Nazareth AM. Type 2 diabetes mellitus in the pathophysiology of Alzheimer\u2019s disease. Dement Neuropsychol. 2017;11:105\u201313.","journal-title":"Dement Neuropsychol"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/13506120009146245","volume":"7","author":"J Wegiel","year":"2000","unstructured":"Wegiel J, Wisniewski HM, Muzylak M, Tarnawski M, Badmajew E, Nowakowski J, et al. Fibrillar amyloid-beta production, accumulation, and recycling in transgenic mice pancreatic acinar cells and macrophages. Amyloid. 2000;7:95\u2013104.","journal-title":"Amyloid"},{"key":"239_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2001-3405","volume":"3","author":"DJ Figueroa","year":"2001","unstructured":"Figueroa DJ, Shi XP, Gardell SJ, Austin CP. Abetapp secretases are co-expressed with Abetapp in the pancreatic islets. J Alzheimers Dis. 2001;3:393\u201396.","journal-title":"J Alzheimers Dis"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/MNM.0000000000000849","volume":"39","author":"Z Lu","year":"2018","unstructured":"Lu Z, Xie J, Yan R, Yu Z, Sun Z, Yu F, et al. A pilot study of pancreatic islet amyloid PET imaging with [18F]FDDNP. Nucl Med Commun. 2018;39:659\u201364.","journal-title":"Nucl Med Commun"},{"key":"239_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"IV Kurochkin","year":"2018","unstructured":"Kurochkin IV, Guarnera E, Berezovsky IN. Insulin-degrading enzyme in the fight against Alzheimer\u2019s disease. Trends Pharm Sci. 2018;39:49\u201358.","journal-title":"Trends Pharm Sci"},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/ijms17040503","volume":"17","author":"N Kimura","year":"2016","unstructured":"Kimura N. Diabetes mellitus induces Alzheimer\u2019s disease pathology: histopathological evidence from animal models. Int J Mol Sci. 2016;17:503.","journal-title":"Int J Mol Sci"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3233\/JAD-161192","volume":"59","author":"P Bharadwaj","year":"2017","unstructured":"Bharadwaj P, Wijesekara N, Liyanapathirana M, Newsholme P, Ittner L, Fraser P, et al. The link between type 2 diabetes and neurodegeneration: roles for amyloid-beta, amylin, and tau proteins. J Alzheimers Dis. 2017;59:421\u201332.","journal-title":"J Alzheimers Dis"},{"key":"239_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s10072-015-2352-5","volume":"36","author":"S Ahmed","year":"2015","unstructured":"Ahmed S, Mahmood Z, Zahid S. Linking insulin with Alzheimer\u2019s disease: emergence as type III diabetes. Neurol Sci. 2015;36:1763\u201369.","journal-title":"Neurol Sci"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","volume":"15","author":"D Bosco","year":"2011","unstructured":"Bosco D, Fava A, Plastino M, Montalcini T, Pujia A. Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis. J Cell Mol Med. 2011;15:1807\u201321.","journal-title":"J Cell Mol Med"},{"key":"239_CR15","first-page":"E584","volume":"314","author":"JK Morris","year":"2018","unstructured":"Morris JK, Piccolo BD, Shankar K, Thyfault JP, Adams SH. The serum metabolomics signature of type 2 diabetes is obscured in Alzheimer\u2019s disease. Am J Physiol Endocrinol Metab. 2018;314:E584\u201396.","journal-title":"Am J Physiol-Endoc M"},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/ndt\/gfr368","volume":"27","author":"F Zhong","year":"2012","unstructured":"Zhong F, Liu X, Zhou Q, Hao X, Lu Y, Guo S, et al. 1H NMR spectroscopy analysis of metabolites in the kidneys provides new insight into pathophysiological mechanisms: applications for treatment with Cordyceps sinensis. Nephrol Dial Transpl. 2012;27:556\u201365.","journal-title":"Nephrol Dial Transpl"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/aps.2013.186","volume":"35","author":"X Liu","year":"2014","unstructured":"Liu X, Zhong F, Tang XL, Lian FL, Zhou Q, Guo SM, et al. Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis. Acta Pharm Sin. 2014;35:697\u2013706.","journal-title":"Acta Pharm Sin"},{"key":"239_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-016-0256-9","volume":"17","author":"T Zhang","year":"2016","unstructured":"Zhang T, Wang W, Huang J, Liu X, Zhang H, Zhang N. Metabolomic investigation of regional brain tissue dysfunctions induced by global cerebral ischemia. BMC Neurosci. 2016;17:25.","journal-title":"BMC Neurosci"},{"key":"239_CR19","first-page":"508302","volume":"2015","author":"HF Ma","year":"2015","unstructured":"Ma HF, Liu X, Wu Y, Zhang NX. The intervention effects of acupuncture on fatigue induced by exhaustive physical exercises: a metabolomics investigation. Evid Based Complement Altern Med. 2015;2015:508302.","journal-title":"Evid Based Complement Altern Med"},{"key":"239_CR20","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/jnr.21787","volume":"86","author":"CG Jolivalt","year":"2008","unstructured":"Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer\u2019s disease and correction by insulin. J Neurosci Res. 2008;86:3265\u201374.","journal-title":"J Neurosci Res"},{"key":"239_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"J Janson","year":"2004","unstructured":"Janson J, Laedtke T, Parisi JE, O\u2019Brien P, Petersen RC, Butler PC. Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004;53:474\u201381.","journal-title":"Diabetes"},{"key":"239_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease - is this type 3 diabetes? J Alzheimers Dis. 2005;7:63\u201380.","journal-title":"J Alzheimers Dis"},{"key":"239_CR23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122:1316\u201338.","journal-title":"J Clin Invest"},{"key":"239_CR24","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1073\/pnas.1000645107","volume":"107","author":"S Takeda","year":"2010","unstructured":"Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and A beta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA. 2010;107:7036\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"E1373","DOI":"10.1152\/ajpendo.00500.2011","volume":"302","author":"M Jimenez-Palomares","year":"2012","unstructured":"Jimenez-Palomares M, Ramos-Rodriguez JJ, Lopez-Acosta JF, Pacheco-Herrero M, Lechuga-Sancho AM, Perdomo G, et al. Increased A beta production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab. 2012;302:E1373\u201380.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"239_CR26","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1096\/fj.201700431R","volume":"31","author":"N Wijesekara","year":"2017","unstructured":"Wijesekara N, Ahrens R, Sabale M, Wu L, Ha K, Verdile G, et al. Amyloid-beta and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model. FASEB J. 2017;31:5409\u201318.","journal-title":"FASEB J"},{"key":"239_CR27","first-page":"595","volume":"15","author":"T Gebregiworgis","year":"2012","unstructured":"Gebregiworgis T, Powers R. Application of NMR metabolomics to search for human disease biomarkers. Comb Chem High T Scr. 2012;15:595\u2013610.","journal-title":"Comb Chem High T Scr"},{"key":"239_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/mrc.3985","volume":"51","author":"AH Zhang","year":"2013","unstructured":"Zhang AH, Sun H, Qiu S, Wang XJ. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magn Reson Chem. 2013;51:549\u201356.","journal-title":"Magn Reson Chem"},{"key":"239_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.envint.2014.03.015","volume":"68","author":"I Dudka","year":"2014","unstructured":"Dudka I, Kossowska B, Senhadri H, Latajka R, Hajek J, Andrzejak R, et al. Metabonomic analysis of serum of workers occupationally exposed to arsenic, cadmium and lead for biomarker research: a preliminary study. Environ Int. 2014;68:71\u201381.","journal-title":"Environ Int"},{"key":"239_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3389\/fnagi.2016.00041","volume":"8","author":"H Koivisto","year":"2016","unstructured":"Koivisto H, Leinonen H, Puurula M, Hafez HS, Barrera GA, Stridh MH, et al. Chronic pyruvate supplementation increases exploratory activity and brain energy reserves in young and middle-aged mice. Front Aging Neurosci. 2016;8:41.","journal-title":"Front Aging Neurosci"},{"key":"239_CR31","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1159\/000471869","volume":"41","author":"B Han","year":"2017","unstructured":"Han B, Wang JH, Geng Y, Shen L, Wang HL, Wang YY, et al. Chronic stress contributes to cognitive dysfunction and hippocampal metabolic abnormalities in APP\/PS1 mice. Cell Physiol Biochem. 2017;41:1766\u201376.","journal-title":"Cell Physiol Biochem"},{"key":"239_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11011-018-0274-7","volume":"33","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Zheng H, Chen JX, Li C, Du Y, Xia HH, et al. Metabolic fate of glucose in the brain of APP\/PS1 transgenic mice at 10 months of age: a C-13 NMR metabolomic study. Metab Brain Dis. 2018;33:1661\u201368.","journal-title":"Metab Brain Dis"},{"key":"239_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23955","volume":"74","author":"P Podlesniy","year":"2013","unstructured":"Podlesniy P, Figueiro-Silva J, Llado A, Antonell A, Sanchez-Valle R, Alcolea D, et al. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol. 2013;74:655\u201368.","journal-title":"Ann Neurol"},{"key":"239_CR34","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jpba.2015.01.025","volume":"107","author":"R Gonzalez-Dominguez","year":"2015","unstructured":"Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, Gomez-Ariza JL. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP\/PS1 transgenic model of Alzheimer\u2019s disease. J Pharm Biomed. 2015;107:378\u201385.","journal-title":"J Pharm Biomed"},{"key":"239_CR35","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jchromb.2018.06.032","volume":"1092","author":"HL Gao","year":"2018","unstructured":"Gao HL, Zhang AH, Yu JB, Sun H, Kong L, Wang XQ, et al. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer\u2019s disease in APP\/PS1 transgenic mice. J Chromatogr B. 2018;1092:286\u201395.","journal-title":"J Chromatogr B"},{"key":"239_CR36","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fneur.2018.00412","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Chen DL, Yang J, Liu T, Hu GY, Liang HL, et al. Effects of oligosaccharides from morinda officinalis on gut microbiota and metabolome of APP\/PS1 transgenic mice. Front Neurol. 2018;9:412.","journal-title":"Front Neurol"},{"key":"239_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12871-018-0509-5","volume":"18","author":"A Woodhouse","year":"2018","unstructured":"Woodhouse A, Fernandez-Martos CM, Atkinson RAK, Hanson KA, Collins JM, O\u2019Mara AR, et al. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP\/PS1 Alzheimer\u2019s disease mice. BMC Anesth. 2018;18:47.","journal-title":"BMC Anesth"},{"key":"239_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/hmg\/ddh019","volume":"13","author":"JL Jankowsky","year":"2004","unstructured":"Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004;13:159\u201370.","journal-title":"Hum Mol Genet"},{"key":"239_CR39","doi-asserted-by":"publisher","first-page":"e42823","DOI":"10.1371\/journal.pone.0042823","volume":"7","author":"W Kamphuis","year":"2012","unstructured":"Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AHP, et al. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS ONE. 2012;7:e42823.","journal-title":"PLoS ONE"},{"key":"239_CR40","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/ejn.13442","volume":"44","author":"RJ Jackson","year":"2016","unstructured":"Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, et al. Human tau increases amyloid beta plaque size but not amyloid beta-mediated synapse loss in a novel mouse model of Alzheimer\u2019s disease. Eur J Neurosci. 2016;44:3056\u201366.","journal-title":"Eur J Neurosci"},{"key":"239_CR41","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/ijms19082333","volume":"19","author":"YH Lee","year":"2018","unstructured":"Lee YH, Hsu HC, Kao PC, Shiao YJ, Yeh SHH, Shie FS, et al. Augmented insulin and leptin resistance of high fat diet-fed APPswe\/PS1dE9 transgenic mice exacerbate obesity and glycemic dysregulation. Int J Mol Sci. 2018;19:2333.","journal-title":"Int J Mol Sci"},{"key":"239_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2337\/diacare.15.3.442","volume":"15","author":"JL Leahy","year":"1992","unstructured":"Leahy JL, Bonnerweir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia - current ideas on mechanism of impaired glucose-induced insulin-secretion. Diabetes Care. 1992;15:442\u201355.","journal-title":"Diabetes Care"},{"key":"239_CR43","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jnr.23777","volume":"95","author":"MA Daulatzai","year":"2017","unstructured":"Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer\u2019s disease. J Neurosci Res. 2017;95:943\u201372.","journal-title":"J Neurosci Res"},{"key":"239_CR44","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2174\/1389450111007011193","volume":"11","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF. Multiple defects in energy metabolism in Alzheimer\u2019s disease. Curr Drug Targets. 2010;11:1193\u2013206.","journal-title":"Curr Drug Targets"},{"key":"239_CR45","doi-asserted-by":"publisher","first-page":"e0185926","DOI":"10.1371\/journal.pone.0185926","volume":"12","author":"L Mosconi","year":"2017","unstructured":"Mosconi L, Berti V, Guyara-Quinn C, McHugh P, Petrongolo G, Osorio RS, et al. Perimenopause and emergence of an Alzheimer\u2019s bioenergetic phenotype in brain and periphery. PLoS ONE. 2017;12:e0185926.","journal-title":"PLoS ONE"},{"key":"239_CR46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tox.2010.01.003","volume":"269","author":"J Das","year":"2010","unstructured":"Das J, Ghosh J, Manna P, Sil PC. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology. 2010;269:24\u201334.","journal-title":"Toxicology"},{"key":"239_CR47","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bcp.2011.01.008","volume":"81","author":"J Das","year":"2011","unstructured":"Das J, Ghosh J, Manna P, Sil PC. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K\/Akt and inhibition of p53, p38-JNK. Biochem Pharm. 2011;81:891\u2013909.","journal-title":"Biochem Pharm"},{"key":"239_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.taap.2014.06.029","volume":"279","author":"CY Chang","year":"2014","unstructured":"Chang CY, Shen CY, Kang CK, Sher YP, Sheu WHH, Chang CC, et al. Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic pathways. Toxicol Appl Pharm. 2014;279:351\u201363.","journal-title":"Toxicol Appl Pharm"},{"key":"239_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/03009740510026878","volume":"35","author":"S Yardim-Akaydin","year":"2006","unstructured":"Yardim-Akaydin S, Sepici A, Ozkan Y, Simsek B, Sepici V. Evaluation of allantoin levels as a new marker of oxidative stress in Behcet\u2019s disease. Scand J Rheuma. 2006;35:61\u201364.","journal-title":"Scand J Rheuma"},{"key":"239_CR50","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li T, Zhang Z, Kolwicz SC, Abell L, Roe ND, Kim M, et al. Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab. 2017;25:374\u201385.","journal-title":"Cell Metab"},{"key":"239_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311\u201326.","journal-title":"Cell Metab"},{"key":"239_CR52","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","volume":"12","author":"HH Ruiz","year":"2016","unstructured":"Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, et al. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement. 2016;12:851\u201361.","journal-title":"Alzheimers Dement"},{"key":"239_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-016-0282-y","volume":"4","author":"EM Knight","year":"2016","unstructured":"Knight EM, Ruiz HH, Kim SH, Harte JC, Hsieh W, Glabe C, et al. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer\u2019s APP\/PSEN1 mice by gene targeting of diabetes\/Alzheimer\u2019s-related Sorcs1. Acta Neuropathol Commun. 2016;4:16.","journal-title":"Acta Neuropathol Commun"},{"key":"239_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuropharm.2017.11.027","volume":"136","author":"N Wijesekara","year":"2018","unstructured":"Wijesekara N, Goncalves RA, De Felice FG, Fraser PE. Impaired peripheral glucose homeostasis and Alzheimer\u2019s disease. Neuropharmacology. 2018;136:172\u201381.","journal-title":"Neuropharmacology"},{"key":"239_CR55","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.2174\/092986710791299902","volume":"17","author":"O Yoshinari","year":"2010","unstructured":"Yoshinari O, Igarashi K. Anti-diabetic effect of trigonelline and nicotinic acid, on KK-A(y) mice. Curr Med Chem. 2010;17:2196\u2013202.","journal-title":"Curr Med Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0239-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0239-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:01:57Z","timestamp":1684616517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0239-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0239-3","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"16 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}